1991
Zidovudine use in AIDS-free HIV-1-seropositive homosexual men in the Multicenter AIDS Cohort Study (MACS), 1987-1989.
Graham NM, Zeger SL, Kuo V, Jacobson LP, Vermund SH, Phair JP, Detels R, Rinaldo CR, Saah AJ. Zidovudine use in AIDS-free HIV-1-seropositive homosexual men in the Multicenter AIDS Cohort Study (MACS), 1987-1989. JAIDS Journal Of Acquired Immune Deficiency Syndromes 1991, 4: 267-76. PMID: 1671411.Peer-Reviewed Original ResearchConceptsHIV-1 seropositive homosexual menZidovudine useVisit 11Clinical variablesClinical trialsHomosexual menVisit 7Multicenter AIDS Cohort StudyLymphocytes/mm3Major clinical variablesClinical trial participationAIDS Cohort StudyClinical trial participantsSeropositive participantsZidovudine therapyCohort studyHigher treatment ratesLymphocyte levelsLymphocyte numbersNonclinical factorsAIDS patientsTrial participationSymptom statusOverall prevalenceOdds ratio
1989
ESTIMATING POPULATION PREVALENCE OF HUMAN IMMUNODEFICIENCY VIRUS INFECTION IN URBAN AREAS WITH HIGH RATES OF INTRAVENOUS DRUG USE: A MODEL OF THE BRONX IN 1988
DRUCKER E, VERMUND S. ESTIMATING POPULATION PREVALENCE OF HUMAN IMMUNODEFICIENCY VIRUS INFECTION IN URBAN AREAS WITH HIGH RATES OF INTRAVENOUS DRUG USE: A MODEL OF THE BRONX IN 1988. American Journal Of Epidemiology 1989, 130: 133-142. PMID: 2787104, DOI: 10.1093/oxfordjournals.aje.a115304.Peer-Reviewed Original ResearchConceptsIntravenous drug usersDrug usersAIDS casesIntravenous drug-using populationHuman immunodeficiency virus (HIV) infectionImmunodeficiency virus infectionIntravenous drug useHuman immunodeficiency virusAge group 25HIV prevalence estimatesAge 13 yearsDrug-using populationsHIV seroprevalenceImmunodeficiency syndromeAIDS patientsImmunodeficiency virusRisk factorsVirus infectionUse populationGroup 25Seroprevalence rangesPopulation prevalencePrevalence estimatesDrug useHigh rate